

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | Soluble guanylyl cyclase (sGC) is the principal enzyme in mediating the biological actions of nitric oxide. On activation, sGC converts guanosine triphosphate to guanosine 3',5'-cyclic monophosphate (cGMP), which mediates diverse physiological processes including vasodilation, platelet aggregation, and myocardial functions predominantly by acting on cGMP-dependent protein kinases[1].Impaired NO-sGC-cGMP signaling could lead to osteoblast apoptosis by mechanisms involving the oxidative-stress-induced shift of the redox state of the reduced heme to oxidized sGC, leading to diminished heme binding to the enzyme and rendering the sGC unresponsive to NO. Targeting oxidized sGC to enhance cGMP production could restore proliferation and differentiation of osteoblasts into osteocytes[2]. ODQ is a potent and selective sGC inhibitor. ODQ enhances the pro-apoptotic effects of Cisplatin in human mesothelioma cells. At 30 and 50 μM, ODQ causes significant induction of apoptosis in the NCI-H2452 cells, elevating apoptotic levels by 12 fold and 15 fold, respectively. At 10μM, a concentration below the threshold for induction of apoptosis by ODQ, ODQ in combination with Cisplatin enhanced (in fact, doubled) the pro-apoptotic effects of Cisplatin at 1 μM[3]. ODQ (2 mg/kg; i.p.) reduces the multiple organ injury and dysfunction caused by wall fragments of Gram-positive or Gram-negative bacteria in the anesthetized rat[4]. |
| Concentration | Treated Time | Description | References | |
| DU-145 cells | 50 µM | 48 hours | ODQ activated caspase-3 at 50 μM, promoting apoptosis. | Br J Pharmacol. 2008 Nov;155(6):804-13 |
| PC-3 cells | 50 µM | 48 hours | ODQ activated caspase-3 at 50 μM, promoting apoptosis. | Br J Pharmacol. 2008 Nov;155(6):804-13 |
| Human platelets | 10 µM | 10 min | ODQ inhibited VASP phosphorylation, but after prolonged incubation (3 min or longer) with NO donor, VASP phosphorylation signals recovered. | Br J Pharmacol. 2013 Sep;170(2):317-27 |
| Murine platelets | 10 µM | 10 min | ODQ reduced NO-induced cGMP increases, but at high NO donor concentrations (100 μM DEA-NO), ODQ lost its inhibitory effect. | Br J Pharmacol. 2013 Sep;170(2):317-27 |
| HEK-GC cells | 1, 10, 100 µM | 10 min | ODQ reduced NO-induced cGMP increases, but even at a concentration of 100 μM ODQ the NO-induced cGMP production was not completely abrogated. | Br J Pharmacol. 2013 Sep;170(2):317-27 |
| Cytosolic extracts from aortic rings and cardiomyocytes | 50 µM | 10 minutes | To investigate the effects of ODQ on SNAP-induced increases in cGMP levels. In cytosolic extracts, ODQ reduced these effects by about 50%. | Br J Pharmacol. 1999 Jun;127(3):693-700 |
| Rat ventricular cardiomyocytes | 50 µM | 10 minutes | To investigate the effects of ODQ on SNAP-, DETA NONOate-, and carbachol-induced increases in cGMP levels. In cardiomyocytes, ODQ did not affect these effects. | Br J Pharmacol. 1999 Jun;127(3):693-700 |
| Rat aortic rings | 50 µM | 10 minutes | To investigate the effects of ODQ on SNAP-, DETA NONOate-, and carbachol-induced increases in cGMP levels. In aortic rings, ODQ completely abolished these effects. | Br J Pharmacol. 1999 Jun;127(3):693-700 |
| Rat coronary arteries | 5 µM | 20 minutes | To investigate the effect of ODQ on dapagliflozin-induced vasodilation, results showed that ODQ did not affect dapagliflozin-induced vasodilation. | Int J Mol Sci. 2023 Nov 28;24(23):16873 |
| HEK293 cells | 10 µM | 30 minutes | Measure intracellular cGMP levels, ODQ inhibited the effects of VL-102 and YC-1. | Cephalalgia. 2018 Jul;38(8):1471-1484 |
| Normal human prostate epithelial cells (HPrECs) | 10 µM | 48 hours | ODQ at 10 μM did not activate caspase-3, indicating no apoptotic effect on normal cells. | Br J Pharmacol. 2008 Nov;155(6):804-13 |
| LNCaP cells | 0.1 µM to 100 µM | 48 hours | ODQ activated caspase-3 at 50 and 100 μM, promoting apoptosis, and caused DNA fragmentation and nucleosome accumulation at 100 μM. | Br J Pharmacol. 2008 Nov;155(6):804-13 |
| Administration | Dosage | Frequency | Description | References | ||
| C57BL6/J mice | Chronic nitroglycerin migraine model | Intraperitoneal injection | 1 mg/kg | Every other day for 9 days | ODQ completely blocked acute and chronic hyperalgesia induced by nitroglycerin. | Cephalalgia. 2018 Jul;38(8):1471-1484 |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
5.34mL 1.07mL 0.53mL |
26.72mL 5.34mL 2.67mL |
53.43mL 10.69mL 5.34mL |
|
| CAS号 | 41443-28-1 |
| 分子式 | C9H5N3O2 |
| 分子量 | 187.15 |
| SMILES Code | O=C1ON=C2N1C3=C(C=CC=C3)N=C2 |
| MDL No. | MFCD00792620 |
| 别名 | 1H-ODQ |
| 运输 | 蓝冰 |
| InChI Key | LZMHWZHOZLVYDL-UHFFFAOYSA-N |
| Pubchem ID | 1456 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, 2-8°C |
| 溶解方案 |
DMSO: 105 mg/mL(561.03 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1